Government Agencies

This report summarizes that the third WHS was held as a predominately virtual event in 2022, with a small in-person hub at the World Health Organization in Geneva, with the theme of “Achieving the elimination of viral hepatitis within evolving health systems”. The programme introduced the new Global Health Sector Strategy (2022-2030) and explored topics across the cascade of care for hepatitis A, B, C, D and E, including barriers such as stigma and discrimination and innovations, like the potential for a functional cure for hepatitis B.

This webinar brings together clinicians, academics, researchers, advocates, professional societies, regulatory agencies and industry representatives to align on best practices to improve treatment for HCV in pregnancy. The TiP-HepC Community of Practice is intended for all stakeholders involved in the care of hepatitis C infection in pregnancy.

The purpose of this toolkit is to help guide jurisdictions in organizing, supporting, and growing viral hepatitis coalitions that are community-oriented and effective in developing, implementing, and evaluating a viral hepatitis strategic plan.

This toolkit is intended to assist health department viral hepatitis programs to assess viral hepatitis testing in laboratories operating in their jurisdictions.

This new Road Map charts a way forward for country-level actions to achieve an ambitious set of HIV prevention targets by 2025. Those targets emerged from the 2021 Political Declaration on HIV and AIDS, which the United Nations General Assembly adopted in June 2021 and they are underpinned by the Global AIDS Strategy (2021–2026). The Strategy sets out the principles, approaches, priority action area and programmatic targets for the global HIV response

The webinar series focused on best practices and strategies for effectively using HIV data for successful programmatic and systematic outcomes in state, local, territorial, and tribal (STLT) health departments. The first webinar focused on data reporting to multiple funding streams. The second webinar covered how to use surveillance data to inform HIV programs. The final webinar was an interactive and engaging session for EHE jurisdictions to discuss best practices for completing CDC-PS20-2010 activities. 

The interagency field guide contains information on strategic approaches, guidance, and innovations for TB prevention and care interventions in humanitarian settings. The guide focuses on the managerial/organizational aspects of TB interventions. References are also provided for the clinical aspects of TB interventions.

This resource provides sample materials, considerations, and resources to assist health departments with developing and implementing a table-top activity in their respective communities.

On Thursday, December 9, HIV.gov hosted “The Updated National HIV/AIDS Strategy: What’s New and What’s Next? A Webinar on How to Use the Strategy ”, led by Harold Phillips, Director, The White House Office of National AIDS Policy (ONAP). Topics included how the Strategy can be used in communities, as well as how community-based organizations and federal officials plan to use the Strategy within their own communities and departments.

This National HIV/AIDS Strategy (the Strategy), the nation’s third national HIV strategy, updates the HIV National Strategic Plan (2021). The Strategy sets forth bold targets for ending the HIV epidemic in the United States by 2030, including a 75% reduction in new HIV infections by 2025 and a 90% reduction by 2030